Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Juan, PR
NPI
1063962058
Since 2016
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1492 Ave Ponce de Leon Ste 502
San Juan, PR, 00907
Phone (787) 723-5017
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
146 services
Medicare patients, 2024
54
Average age 74
Drug cost, 2024
$725K
2,261 prescriptions
Company payments, 2025
$1,272
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Monica A Ortiz-Rivera was code 99214 (office e&m - established), 45 times for 28 patients. In total Monica A Ortiz-Rivera billed 146 services in 9 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 45 | 28 | $94.69 | $4,261 |
| 99213 Office E&M - Established | Office | 33 | 23 | $67.67 | $2,233 |
| 99203 Office E&M - New | Office | 24 | 24 | $64.66 | $1,552 |
| 99204 Office E&M - New | Office | 22 | 22 | $113.82 | $2,504 |
Medicare prescription drug claims, 2024
In 2024, the drug Monica A Ortiz-Rivera prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 303 prescriptions and refills. In total Monica A Ortiz-Rivera wrote 2,261 Medicare prescriptions that cost $725K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 303 | 586 | 83 | $23K |
| Metformin Hcl Er Metformin Hcl | 155 | 254 | 53 | $1,453 |
| Lantus Insulin Glargine,hum.Rec.Anlog | 103 | 122 | 21 | $11K |
| Jentadueto Xr Linagliptin/Metformin Hcl | 99 | 107 | 19 | $57K |
| Ozempic Semaglutide | 99 | 111 | 21 | $103K |
| Humalog Insulin Lispro | 81 | 85 | 14 | $8,547 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 81 | 87 | 21 | $53K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 73 | 83 | 14 | $52K |
| Jardiance Empagliflozin | 71 | 109 | 26 | $66K |
| Mounjaro Tirzepatide | 71 | 71 | 12 | $76K |
| Janumet Xr Sitagliptin Phos/Metformin Hcl | 67 | 95 | 21 | $52K |
| Atorvastatin Calcium Generic | 62 | 124 | 20 | $552 |
| Metformin Hcl Generic | 58 | 152 | 25 | $476 |
| Tradjenta Linagliptin | 54 | 66 | 14 | $34K |
| Glyxambi Empagliflozin/Linagliptin | 47 | 57 | Under 11 | $35K |
Brand drugs: 1,409 claims; generic drugs: 796 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Monica A Ortiz-Rivera $1,272 ($1,272 in general payments such as food, travel and fees) from 12 companies. The largest payer was Novo Nordisk Inc with $269.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 11 | $269 |
| Dexcom, Inc. DXCM | 7 | $226 |
| Lilly USA, LLC LLY | 2 | $221 |
| Beta Bionics, Inc. BBNX | 1 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $107 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $80.18 |
| Scpharmaceuticals Inc. SCPH | 3 | $58.96 |
| Bayer Puerto Rico Inc. BAYN.DE | 3 | $54.94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| Vifor Pharma, Inc. | 2 | $43.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.